Par Pursuing Settlement Of FDA Suit And DoJ Off-Label Investigation
This article was originally published in The Pink Sheet Daily
Executive Summary
Parties have stayed their litigation as they continue to hammer out a potential global resolution that would also settle DoJ’s investigation of Megace sales and marketing practices.